EXTON, Pa., Jan. 9 /PRNewswire-FirstCall/ -- Kensey Nash Corporation today announced that it will release its earnings results for its second quarter ended December 31, 2005, at 8:00 a.m. Eastern Standard Time on Monday, January 30, 2006.
Joseph Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Monday, January 30, 2006 at 9:00 a.m. Eastern Standard Time. To participate in the teleconference call, dial 1-800-428-4474.
The teleconference call will also be available for replay starting Monday, January 30, 2006 at 12:30 p.m. Eastern Standard Time through Tuesday, February 7, 2006 at 11:59 p.m. Eastern Standard Time by dialing 1-800-475-6701 with an access code of 813618.
Individuals interested in listening to the teleconference may also do so over the Internet at http://www.kenseynash.com. To listen to the live teleconference call, please go to http://www.kenseynash.com and choose the Investor Relations Page. Please allow fifteen minutes prior to the start of the call to register and download and/or install any necessary software. A replay of the teleconference will be archived on the Kensey Nash website and may be accessed following the teleconference.
About Kensey Nash Corporation. Kensey Nash Corporation is a leading developer and manufacturer of medical devices with applications in the cardiology, orthopaedics, spine, drug and biologics delivery, periodontal/dental, surgical and wound care markets. The Company's endovascular product platform currently includes the TriActiv(R) System, a novel embolic protection system, which is approved for sale in the U.S., as well as the TriActiv(R) FX(TM) System, the second generation of the TriActiv(R) System, which is approved for sale in the European Union and has been studied in a clinical trial to gain regulatory approval in the U.S. The Company was a pioneer in the field of absorbable biomaterials-based products and in arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.
Statements made during the presentation that are not historical facts are forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company cautions that a number of important factors could cause the Company's actual results to differ materially from those in the forward-looking statements. For a more detailed discussion of these and other factors, please see the Company's SEC filings. Results of operations in any past period should not be considered indicative of the results to be expected for future periods. Fluctuations in operating results may also result in fluctuations in the price of the Common stock.
Kensey Nash CorporationCONTACT: Joseph W. Kaufmann, President and Chief Executive Officer, KenseyNash Corporation, +1-484-713-2100
Web site: http://www.kenseynash.com//
